HOB Net Receivables from 2010 to 2024
| 688656 Stock | 107.02 4.43 3.97% |
Net Receivables | First Reported 2010-12-31 | Previous Quarter 41.5 M | Current Value 35.5 M | Quarterly Volatility 7.9 M |
Check HOB Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among HOB Biotech's main balance sheet or income statement drivers, such as Depreciation And Amortization of 40.2 M, Interest Expense of 1.9 M or Selling General Administrative of 110.9 M, as well as many indicators such as . HOB financial statements analysis is a perfect complement when working with HOB Biotech Valuation or Volatility modules.
HOB | Net Receivables |
Currently Active Assets on Macroaxis
Other Information on Investing in HOB Stock
HOB Biotech financial ratios help investors to determine whether HOB Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HOB with respect to the benefits of owning HOB Biotech security.